Medical decision analysis for first-line therapy of chronic myeloid leukemia.
about
The role of dasatinib in the management of chronic myeloid leukemiaEffectiveness and Cost-Effectiveness of Sequential Treatment of Patients with Chronic Myeloid Leukemia in the United States: A Decision AnalysisCost-effectiveness of the sequential application of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia.
P2860
Medical decision analysis for first-line therapy of chronic myeloid leukemia.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Medical decision analysis for first-line therapy of chronic myeloid leukemia.
@en
Medical decision analysis for first-line therapy of chronic myeloid leukemia.
@nl
type
label
Medical decision analysis for first-line therapy of chronic myeloid leukemia.
@en
Medical decision analysis for first-line therapy of chronic myeloid leukemia.
@nl
prefLabel
Medical decision analysis for first-line therapy of chronic myeloid leukemia.
@en
Medical decision analysis for first-line therapy of chronic myeloid leukemia.
@nl
P2093
P2860
P1433
P1476
Medical decision analysis for first-line therapy of chronic myeloid leukemia
@en
P2093
Annette Conrads-Frank
Beate Jahn
Diana Brixner
Dominik Wolf
Gaby Sroczynski
Guenther Gastl
Jerald Radich
Kim Saverno
Stefan Schmidt
Ursula Rochau
P2860
P304
P356
10.3109/10428194.2013.858149
P50
P577
2014-02-06T00:00:00Z